INS and Alzheimer disease: Furthermore, clinical research has shown that insulin therapy improves cognitive performance in both T2DM and AD, indicating that poor insulin signaling may be a major contributor to diabetic cognitive impairment (Novak et al., 2014; Claxton et al., 2015; Chapman et al., 2018).